Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Franssen

Showing results (141-150 of 151) with videos related to

Pageof 16
Sort By:
BMC Cancer|April 7, 2019
Peptide receptor radionuclide therapy in patients with medullary thyroid carcinoma: predictors and pitfallsCarolien M Beukhof, Tessa Brabander, Francien H van Nederveen, et al.
European Journal of Endocrinology|June 25, 2020
Postoperative parathyroid hormone levels as a predictor for persistent hypoparathyroidismIvona Lončar, Roderick R Dulfer, Elske T Massolt, et al.
Endocrine-Related Cancer|August 19, 2016
Methylation of IGF2 regulatory regions to diagnose adrenocortical carcinomasS G Creemers, P M van Koetsveld, F J van Kemenade, et al.
Neurology|September 1, 2010
Correlates of outcome and response to IVIg in 88 patients with multifocal motor neuropathyE A Cats, W-L van der Pol, S Piepers, et al.
EMBO Molecular Medicine|September 1, 2017
TREM2 shedding by cleavage at the H157-S158 bond is accelerated for the Alzheimer's disease-associated H157Y variantPeter Thornton, Jean Sevalle, Michael J Deery, et al.
European Journal of Endocrinology|May 9, 2019
Treatment of inoperable or metastatic paragangliomas and pheochromocytomas with peptide receptor radionuclide therapy using 177Lu-DOTATATEWouter T Zandee, Richard A Feelders, Daan A Smit Duijzentkunst, et al.
Endocrine-Related Cancer|June 22, 2014
Telomerase reverse transcriptase promoter mutations in tumors originating from the adrenal gland and extra-adrenal paragangliaThomas G Papathomas, Lindsey Oudijk, Ellen C Zwarthoff, et al.
The Journal of Clinical Endocrinology and Metabolism|December 17, 2015
Complex MAX Rearrangement in a Family With Malignant Pheochromocytoma, Renal Oncocytoma, and ErythrocytosisEsther Korpershoek, Djamailys Koffy, Bert H Eussen, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|August 21, 2007
Treatment of Guillain-Barré syndrome with mycophenolate mofetil: a pilot studyM P J Garssen, R van Koningsveld, P A van Doorn, et al.
The Journal of Clinical Endocrinology and Metabolism|September 23, 2017
Expression of Contactin 4 Is Associated With Malignant Behavior in Pheochromocytomas and ParagangliomasLucie Evenepoel, Francien H van Nederveen, Lindsey Oudijk, et al.
Pageof 16

Showing results (141-150 of 151) with videos related to

Sort By:
Pageof 16
BMC Cancer|April 7, 2019
Peptide receptor radionuclide therapy in patients with medullary thyroid carcinoma: predictors and pitfallsCarolien M Beukhof, Tessa Brabander, Francien H van Nederveen, et al.
European Journal of Endocrinology|June 25, 2020
Postoperative parathyroid hormone levels as a predictor for persistent hypoparathyroidismIvona Lončar, Roderick R Dulfer, Elske T Massolt, et al.
Endocrine-Related Cancer|August 19, 2016
Methylation of IGF2 regulatory regions to diagnose adrenocortical carcinomasS G Creemers, P M van Koetsveld, F J van Kemenade, et al.
Neurology|September 1, 2010
Correlates of outcome and response to IVIg in 88 patients with multifocal motor neuropathyE A Cats, W-L van der Pol, S Piepers, et al.
EMBO Molecular Medicine|September 1, 2017
TREM2 shedding by cleavage at the H157-S158 bond is accelerated for the Alzheimer's disease-associated H157Y variantPeter Thornton, Jean Sevalle, Michael J Deery, et al.
European Journal of Endocrinology|May 9, 2019
Treatment of inoperable or metastatic paragangliomas and pheochromocytomas with peptide receptor radionuclide therapy using 177Lu-DOTATATEWouter T Zandee, Richard A Feelders, Daan A Smit Duijzentkunst, et al.
Endocrine-Related Cancer|June 22, 2014
Telomerase reverse transcriptase promoter mutations in tumors originating from the adrenal gland and extra-adrenal paragangliaThomas G Papathomas, Lindsey Oudijk, Ellen C Zwarthoff, et al.
The Journal of Clinical Endocrinology and Metabolism|December 17, 2015
Complex MAX Rearrangement in a Family With Malignant Pheochromocytoma, Renal Oncocytoma, and ErythrocytosisEsther Korpershoek, Djamailys Koffy, Bert H Eussen, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|August 21, 2007
Treatment of Guillain-Barré syndrome with mycophenolate mofetil: a pilot studyM P J Garssen, R van Koningsveld, P A van Doorn, et al.
The Journal of Clinical Endocrinology and Metabolism|September 23, 2017
Expression of Contactin 4 Is Associated With Malignant Behavior in Pheochromocytomas and ParagangliomasLucie Evenepoel, Francien H van Nederveen, Lindsey Oudijk, et al.
Pageof 16